![]() |
Volumn 353, Issue 1, 2005, Pages 93-96
|
Intensive lipid lowering with atorvastatin in coronary disease [1] (multiple letters)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTILIPEMIC AGENT;
ATORVASTATIN;
CHOLESTEROL;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
PRAVASTATIN;
SIMVASTATIN;
HEPTANOIC ACID DERIVATIVE;
PYRROLE DERIVATIVE;
AGGRESSION;
AMNESIA;
CARDIOVASCULAR RISK;
CAUSE OF DEATH;
CHOLESTEROL BLOOD LEVEL;
CLINICAL TRIAL;
CONGENITAL MALFORMATION;
CORONARY ARTERY DISEASE;
DRUG MEGADOSE;
DRUG SCREENING;
DRUG USE;
HEART INFARCTION;
HUMAN;
ISCHEMIC HEART DISEASE;
LETTER;
LOW DRUG DOSE;
MORBIDITY;
MORTALITY;
PLEIOTROPY;
POLYNEUROPATHY;
PRIORITY JOURNAL;
RHABDOMYOLYSIS;
SIDE EFFECT;
STROKE;
SUICIDAL BEHAVIOR;
BLOOD;
CARDIOVASCULAR DISEASE;
DOSE RESPONSE;
NOTE;
RISK;
CHEMICALLY INDUCED DISORDER;
CARDIOVASCULAR DISEASES;
CHOLESTEROL, LDL;
CORONARY DISEASE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
HEPTANOIC ACIDS;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
PYRROLES;
RISK;
MORTALITY;
RHABDOMYOLYSIS;
SIMVASTATIN;
CHOLESTEROL, HDL;
PRAVASTATIN;
|
EID: 21444455072
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJM200507073530117 Document Type: Letter |
Times cited : (30)
|
References (0)
|